GLP-1 and Inflammation
Semaglutide measurably lowers a key inflammation marker in trial data, independent of how much weight is lost. Here is w...
Evidence-based, medically reviewed articles on metabolic health, GLP-1 science, nutrition and sustainable weight management.
Semaglutide measurably lowers a key inflammation marker in trial data, independent of how much weight is lost. Here is w...
Semaglutide is being studied specifically for alcohol use disorder, with early trials showing reduced consumption and cr...
Emerging research suggests semaglutide may reduce tobacco use, an unexpected finding still being actively studied. Here...
Weight and mental health influence each other in both directions. Here is how to think about that relationship honestly...
Energy often dips before it improves during weight loss. Here is the realistic timeline and what actually drives the eve...
Beyond the health metrics, weight loss changes ordinary daily tasks in ways people rarely discuss in advance. Here is wh...
Obesity is linked to reduced life expectancy through several major disease pathways. Here is what large trial data shows...
A small pilot study found a GLP-1 medication roughly halved monthly migraine days in people with obesity, independent of...
Insulin sensitivity improves before most weight is lost, through a direct hormonal effect separate from the weight chang...
Physician-authored articles on GLP-1, metabolism and sustainable fat loss, delivered to your inbox.
✓ Subscribed! Check your inbox.
No spam. Unsubscribe anytime.